DK0921807T3 - Hydrogenholdigt lægemiddel - Google Patents

Hydrogenholdigt lægemiddel

Info

Publication number: DK0921807T3
Authority: DK; Denmark
Prior art keywords: hydrogenous; gas mixtures; hydrogen; gas; inflammatory processes
Prior art date: 1996-08-27

Application number

DK97944778T

Other languages

English (en)

Inventor

Christian Krebs

Bonn Rolf Van

Peter Germann

Manfred Eschwey

Original Assignee

Messer Griesheim Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-27

Filing date

1997-08-22

Publication date

2004-03-15

1996-08-27 Priority claimed from DE19634530A external-priority patent/DE19634530A1/de

1997-08-07 Priority claimed from DE1997134279 external-priority patent/DE19734279A1/de

1997-08-22 Application filed by Messer Griesheim Gmbh filed Critical Messer Griesheim Gmbh

2004-03-15 Application granted granted Critical

2004-03-15 Publication of DK0921807T3 publication Critical patent/DK0921807T3/da

Links

239000003814 drug Substances 0.000 title abstract 3
229910052739 hydrogen Inorganic materials 0.000 title abstract 2
239000001257 hydrogen Substances 0.000 title abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000007789 gas Substances 0.000 abstract 5
239000000203 mixture Substances 0.000 abstract 3
MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 2
GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 abstract 2
230000004054 inflammatory process Effects 0.000 abstract 2
UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 abstract 1
YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 abstract 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
239000005977 Ethylene Substances 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
239000000443 aerosol Substances 0.000 abstract 1
HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
239000002775 capsule Substances 0.000 abstract 1
229910002091 carbon monoxide Inorganic materials 0.000 abstract 1
239000000969 carrier Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
229940112822 chewing gum Drugs 0.000 abstract 1
235000015218 chewing gum Nutrition 0.000 abstract 1
229910052805 deuterium Inorganic materials 0.000 abstract 1
239000006185 dispersion Substances 0.000 abstract 1
239000000839 emulsion Substances 0.000 abstract 1
125000002534 ethynyl group Chemical group [H]C#C* 0.000 abstract 1
239000006260 foam Substances 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
239000002502 liposome Substances 0.000 abstract 1
210000004072 lung Anatomy 0.000 abstract 1
239000003094 microcapsule Substances 0.000 abstract 1
239000011859 microparticle Substances 0.000 abstract 1
239000001272 nitrous oxide Substances 0.000 abstract 1
239000002674 ointment Substances 0.000 abstract 1
235000010603 pastilles Nutrition 0.000 abstract 1
239000006187 pill Substances 0.000 abstract 1
239000011505 plaster Substances 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1
239000000829 suppository Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK97944778T 1996-08-27 1997-08-22 Hydrogenholdigt lægemiddel DK0921807T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19634530A DE19634530A1 (de)	1996-08-27	1996-08-27	Mittel und Verfahren zur Veränderung der Bildungsgeschwindigkeit und/oder Halbwertszeit reaktiver Molekülspezies
DE1997134279 DE19734279A1 (de)	1997-08-07	1997-08-07	Wasserstoffhaltiges Medikament
PCT/EP1997/004567 WO1998008523A1 (de)	1996-08-27	1997-08-22	Wasserstoffhaltiges medikament

Publications (1)

Publication Number	Publication Date
DK0921807T3 true DK0921807T3 (da)	2004-03-15

Family

ID=26028775

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97944778T DK0921807T3 (da)	1996-08-27	1997-08-22	Hydrogenholdigt lægemiddel

Country Status (10)

Country	Link
EP (1)	EP0921807B1 (da)
JP (1)	JP2000517311A (da)
CN (1)	CN1191836C (da)
AT (1)	ATE253372T1 (da)
DE (1)	DE59710969D1 (da)
DK (1)	DK0921807T3 (da)
ES (1)	ES2210585T3 (da)
HR (1)	HRP970465A2 (da)
PT (1)	PT921807E (da)
WO (1)	WO1998008523A1 (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8128963B2 (en)	1996-09-27	2012-03-06	The Trustees Of Columbia University In The City Of New York	Methods for treating ischemic disorders using carbon monoxide
DE19833014A1 (de) *	1998-07-23	2000-01-27	Messer Griesheim Gmbh	Edelgashaltige Injektionsanästhesiemittel
US7678390B2 (en) *	1999-04-01	2010-03-16	Yale University	Carbon monoxide as a biomarker and therapeutic agent
FR2812197B1 (fr) *	2000-07-27	2003-01-03	Air Liquide Sante Int	Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
EP1404811B1 (en)	2001-06-21	2008-11-12	Beth Israel Deaconess Medical Center, Inc.	Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
SG148850A1 (en) *	2002-02-13	2009-01-29	Beth Israel Hospital	Methods of treating vascular disease
EA200401365A1 (ru)	2002-04-15	2005-04-28	Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн	Способы лечения илеуса
WO2003088748A1 (en)	2002-04-15	2003-10-30	Beth Israel Deaconess Medical Center	Use of heme oxygenase-1 and products of heme degradation
WO2003088981A1 (en)	2002-04-15	2003-10-30	University Of Pittsburgh Of The Commonwealth System Of Higher Education	Methods of treating necrotizing enterocolitis
US20050170011A1 (en) *	2002-04-26	2005-08-04	Tomoyuki Yanagihara	Method of inhibiting oxidation, water capable of inhibiting oxidation and use thereof
BR0215717A (pt) *	2002-05-09	2005-02-22	Univ Yale	Monóxido de carbono como um biomarcador e agente terapêutico
EA200401525A1 (ru)	2002-05-17	2006-06-30	Йейл Юниверсити	Способы лечения гепатита (варианты )
WO2006064539A1 (ja) *	2004-12-13	2006-06-22	Wataru Murota	還元性生理食塩水及びその製造方法
CA2619769A1 (en)	2005-08-19	2007-02-22	Shigeo Ohta	Scavenger of in vivo harmful reactive oxygen species and/or free radicals
EP2057990A4 (en)	2006-08-31	2010-08-04	Ohta Shigeo	A HYDROGEN MOLECULE-CONTAINING MEANS FOR IMPROVING FATTY CHANGE
DE102008054205A1 (de) *	2008-10-31	2010-05-06	Bayer Schering Pharma Aktiengesellschaft	Verwendung von Helium-Sauerstoff-Gasgemischen zur Behandlung der pulmonalen arteriellen Hypertonie
EP2474327A1 (en)	2011-01-07	2012-07-11	RWTH Aachen	Microdosing of ultrasound contrast agents
CA2830298C (en)	2011-03-17	2016-08-16	Transdermal Biotechnology, Inc.	Topical nitric oxide systems comprising lecithin and methods of use thereof
EP2545908A1 (en)	2011-07-11	2013-01-16	RWTH Aachen	Medium for microbubbles or microparticles and preparation thereof
CN103565822B (zh) *	2012-08-05	2015-03-25	熊江	氢气饱和生理盐水在制备防治腹主动脉瘤药物中的应用
US8871260B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Methods and compositions for muscular and neuromuscular diseases
US8871256B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871261B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Cancer treatments and compositions for use thereof
US8871255B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Treatment of skin and soft tissue infection with nitric oxide
US8871257B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871258B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Treatment and prevention of learning and memory disorders
US8871254B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871262B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Compositions and methods for treatment of osteoporosis and other indications
US8871259B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Techniques and systems for treatment of neuropathic pain and other indications
CN103099780B (zh) *	2012-12-11	2015-11-25	中国科学院深圳先进技术研究院	制备含氢气微泡水溶液的方法，其产品及应用
CA2903968A1 (en)	2013-03-15	2014-09-18	Westfaelische Wilhelms-Universitaet Muenster	Detection of acute renal allograft rejection
JP6572129B2 (ja)	2013-10-31	2019-09-04	山下　直樹	精子運動性改善剤
CN103690481B (zh) *	2013-12-23	2016-09-07	中国人民解放军第二军医大学	甲烷注射液在制备治疗缺血再灌注损伤药物中的应用
TWI590837B (zh) *	2014-03-25	2017-07-11	林信湧	一種用於治療心臟病之吸入式醫藥組成物及其備製方法
TWI586382B (zh) *	2014-04-18	2017-06-11	林信湧	一種用於治療腎臟病之吸入式醫藥組成物及其備製方法
TWI601542B (zh)	2014-04-18	2017-10-11	林信湧	一種用於治療肺癌之吸入式醫藥組成物及其備製方法
TWI590838B (zh) *	2014-04-18	2017-07-11	林信湧	一種用於治療糖尿病之吸入式醫藥組成物及其備製方法
TWI594772B (zh) *	2014-04-18	2017-08-11	林信湧	一種用於治療高血壓之吸入式醫藥組成物及其備製方法
JP2017143752A (ja) *	2016-02-15	2017-08-24	ＨａｃｋＪａｐａｎホールディングス株式会社	サプリメント
EP3484486B9 (en)	2016-07-15	2023-11-01	H2 Water Technologies Ltd	Composition for producing hydrogen rich water
US20200001120A1 (en) *	2017-01-05	2020-01-02	Warren Lee	Apparatus, method, and use for ultrasound mediated microbubble delivery of pharmaceutical compositions
WO2018211474A1 (en)	2017-05-19	2018-11-22	Trudell Medical International	Positive expiratory pressure device
USD903097S1 (en)	2018-05-18	2020-11-24	Trudell Medical International	Mask
USD874064S1 (en)	2018-05-18	2020-01-28	Trudell Medical International	Mask
BR112021000917B1 (pt)	2018-07-23	2023-12-26	Nutragenom, Llc	Solução de glucomanano e composição de geração de h2
JP6628449B1 (ja) *	2018-07-30	2020-01-08	国立大学法人名古屋大学	閉塞性気道疾患の抑制又は軽減のための組成物
USD893806S1 (en)	2018-11-09	2020-08-18	Trudell Medical Internationl	Mask and shroud
JP6667817B1 (ja)	2019-03-13	2020-03-18	住友精化株式会社	ガス組成物及びその製造方法、並びにガス製品
EP4056188A4 (en) *	2019-11-08	2023-12-06	School Juridical Person The Kitasato Institute	MEANS FOR PREVENTING OR TREATING ARRHYTHMIA AND DEVICE FOR PREVENTING OR TREATING ARRHYTHMIA
CN113318123A (zh) *	2020-02-28	2021-08-31	ＭｉＺ株式会社	用于预防和/或改善肺炎的含分子态氢组合物
CN114948990A (zh) *	2021-02-22	2022-08-30	上海市肺科医院	氢化镁在制备防治急性呼吸窘迫综合征疾病药物中的应用
CN114870839B (zh) *	2022-02-15	2023-11-10	中国科学院上海硅酸盐研究所	具有压电催化性能的无机纳米材料和催化制氢纳米反应器及其制备方法和应用
CN119950430B (zh) *	2025-04-11	2025-07-29	浙江奇麟正维医学科技有限公司	一种产氢脂质体的制备方法及产氢脂质体和其在产氢、抗炎及防脱发产品中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE407778B (sv) *	1977-09-06	1979-04-23	Astra Laekemedel Ab	Forpackning och forfarande for skyddande av lekemedelsaktiva losningar innehallande oxidativt nedbrytbara substanser

1997
- 1997-08-22 DK DK97944778T patent/DK0921807T3/da active
- 1997-08-22 CN CNB971975175A patent/CN1191836C/zh not_active Expired - Fee Related
- 1997-08-22 ES ES97944778T patent/ES2210585T3/es not_active Expired - Lifetime
- 1997-08-22 WO PCT/EP1997/004567 patent/WO1998008523A1/de not_active Ceased
- 1997-08-22 DE DE59710969T patent/DE59710969D1/de not_active Expired - Lifetime
- 1997-08-22 JP JP10511253A patent/JP2000517311A/ja active Pending
- 1997-08-22 AT AT97944778T patent/ATE253372T1/de not_active IP Right Cessation
- 1997-08-22 EP EP97944778A patent/EP0921807B1/de not_active Expired - Lifetime
- 1997-08-22 PT PT97944778T patent/PT921807E/pt unknown
- 1997-08-26 HR HR19734279.5A patent/HRP970465A2/hr not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE59710969D1 (de)	2003-12-11
ES2210585T3 (es)	2004-07-01
HRP970465A2 (en)	1998-08-31
EP0921807B1 (de)	2003-11-05
WO1998008523A1 (de)	1998-03-05
CN1191836C (zh)	2005-03-09
PT921807E (pt)	2004-04-30
EP0921807A1 (de)	1999-06-16
JP2000517311A (ja)	2000-12-26
ATE253372T1 (de)	2003-11-15
HK1021885A1 (en)	2000-07-14
CN1228706A (zh)	1999-09-15

Publication	Publication Date	Title
DK0921807T3 (da)	2004-03-15	Hydrogenholdigt lægemiddel
DE69533190D1 (de)	2004-07-29	Behandlung von pulmonaler vasokonstriktion und asthma
MD1900C2 (ro)	2002-12-31	Compoziţie farmaceutică de aerosol şi metodă de tratament al afecţiunilor respiratorii
GB9924999D0 (en)	1999-12-22	Reactor for the plasma treatment of gases
DE69723340D1 (de)	2003-08-14	Herstellung von stickstoffoxydhaltigen Gasgemischen
HUT64567A (en)	1994-01-28	Method for producing new cyclosporines and preparations containing said compounds as active agent
BR9306060A (pt)	1997-11-18	Oxido nitrico de ar para usos medicos
UA27092C2 (uk)	2000-02-28	Спосіб формуваhhя дихальhої газової суміші і апарат для його реалізації
ES2036420T3 (es)	1993-05-16	Catalizador de forma monolitica o alveolar.
BR0207852A (pt)	2004-03-23	Processo para a epoxidação de olefinas
GB0014620D0 (en)	2000-08-09	Reactor
FR2820322B1 (fr)	2005-03-11	Formulation pharmaceutique de propionate de fluticasone
BR9917362A (pt)	2002-02-26	Processo para a purificação de óxido nìtrico
ES2107674T3 (es)	1997-12-01	Catalizador soportado de oxido de aluminio que contiene plata, y procedimiento para la descomposicion de monoxido de dinitrogeno.
ES2102012T3 (es)	1997-07-16	Procedimiento para la conversion de n2o.
PL363860A1 (en)	2004-11-29	Method for the simultaneous removal of nitrogen oxides and laughing gas from a gas stream containing nitrogen oxides and laughing gas.
PT1064945E (pt)	2002-11-29	Utilizacoes terapeuticas da mistura helio/oxigenio particularmente para o tratamento da asma
MY139204A (en)	2009-08-28	Process for the preparation of hydroxylammonium
BR9406272A (pt)	2002-06-18	Processo e aparelho para produzir ferro
CZ220396A3 (en)	1996-12-11	Process of treating a medicament to aerosol, the use of a gas mixture and a therapeutical preparation
JPS6442509A (en)	1989-02-14	Method for killing slag foaming
BR0006237A (pt)	2001-11-27	Inalador em aerossol, e, processo de tratamentode um sujeito com um agente farmacêutico
Patnaik et al.	1988	Radiation decomposition of metal acetyl acetonates
BR0213798B1 (pt)	2009-12-01	processo e aparelho para tratar um material de carga em partìculas finas, em particular contendo metal.
JPS5262168A (en)	1977-05-23	Fixed bed catalytic reactor